ATA903983A - Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung - Google Patents

Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung

Info

Publication number
ATA903983A
ATA903983A AT0903983A AT903983A ATA903983A AT A903983 A ATA903983 A AT A903983A AT 0903983 A AT0903983 A AT 0903983A AT 903983 A AT903983 A AT 903983A AT A903983 A ATA903983 A AT A903983A
Authority
AT
Austria
Prior art keywords
analgetic
producing
pharmaceutical preparation
inflammatory pharmaceutical
inflammatory
Prior art date
Application number
AT0903983A
Other languages
English (en)
Other versions
AT389226B (de
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of ATA903983A publication Critical patent/ATA903983A/de
Application granted granted Critical
Publication of AT389226B publication Critical patent/AT389226B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT0903983A 1982-07-22 1983-07-21 Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung AT389226B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40059782A 1982-07-22 1982-07-22
PCT/US1983/001121 WO1984000488A1 (en) 1982-07-22 1983-07-21 Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same

Publications (2)

Publication Number Publication Date
ATA903983A true ATA903983A (de) 1989-04-15
AT389226B AT389226B (de) 1989-11-10

Family

ID=23584242

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0903983A AT389226B (de) 1982-07-22 1983-07-21 Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung
AT0245988A AT389998B (de) 1982-07-22 1988-10-05 Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT0245988A AT389998B (de) 1982-07-22 1988-10-05 Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung

Country Status (15)

Country Link
JP (3) JPS59501459A (de)
AT (2) AT389226B (de)
AU (1) AU558485B2 (de)
BE (1) BE897356A (de)
CA (1) CA1217429A (de)
CH (1) CH659391A5 (de)
DE (1) DE3390116C2 (de)
FR (1) FR2530469A1 (de)
GB (1) GB2134786B (de)
IE (1) IE55367B1 (de)
IT (1) IT1206502B (de)
NL (1) NL191432C (de)
SE (1) SE466481B (de)
WO (1) WO1984000488A1 (de)
ZA (2) ZA835324B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
CH669523A5 (de) * 1986-06-25 1989-03-31 Mepha Ag
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
DE60219478T2 (de) 2001-07-06 2008-01-03 Endo Pharmaceuticals Inc. Orale gabe von 6-hydroxy-oxymorphon als analgetikum
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US7914831B2 (en) * 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
JP2006282644A (ja) * 2005-04-05 2006-10-19 Idemitsu Kosan Co Ltd 疲労回復剤
TW201247195A (en) * 2011-04-28 2012-12-01 Kowa Co Stable pharmaceutical composition
JP2018076305A (ja) * 2016-10-31 2018-05-17 エスエス製薬株式会社 医薬組成物
JP6811453B1 (ja) * 2020-06-24 2021-01-13 医療法人すぎやま内科 経皮吸収用組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439094A (en) * 1967-07-20 1969-04-15 Warner Lambert Pharmaceutical Analgesic compositions containing namol xenyrate,caffeine and acetyl-rho-aminophenol
US4049803A (en) * 1976-04-26 1977-09-20 Bristol-Myers Company Augmentation of blood levels of aspirin
JPS5423132A (en) * 1977-07-19 1979-02-21 Dai Ichi Seiyaku Co Ltd Analgesic composition
JPS54154416A (en) * 1978-05-26 1979-12-05 Tdk Electronics Co Ltd High dielectric constant porcelain composition
US4233315A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4234601A (en) * 1978-12-18 1980-11-18 Mcneilab, Inc. Analgesic potentiation
US4233317A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233314A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233316A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4237140A (en) * 1979-05-18 1980-12-02 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and acetaminophen
US4315936A (en) * 1979-12-17 1982-02-16 Ortho Pharmaceutical Corporation Analgesic composition
JPS56154416A (en) * 1980-04-30 1981-11-30 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same

Also Published As

Publication number Publication date
CA1217429A (en) 1987-02-03
BE897356A (fr) 1983-11-14
JPH07165583A (ja) 1995-06-27
IE55367B1 (en) 1990-08-29
AU1881683A (en) 1984-02-23
ATA245988A (de) 1989-08-15
GB8406704D0 (en) 1984-04-18
JPS59501459A (ja) 1984-08-16
ZA835326B (en) 1984-09-26
GB2134786A (en) 1984-08-22
FR2530469A1 (fr) 1984-01-27
NL191432C (nl) 1995-07-04
SE466481B (sv) 1992-02-24
DE3390116C2 (de) 1994-06-16
CH659391A5 (de) 1987-01-30
IE831715L (en) 1984-01-22
JPS59501460A (ja) 1984-08-16
AU558485B2 (en) 1987-01-29
NL8320240A (nl) 1984-06-01
IT1206502B (it) 1989-04-27
AT389226B (de) 1989-11-10
NL191432B (nl) 1995-03-01
GB2134786B (en) 1986-05-08
IT8322173A0 (it) 1983-07-21
AT389998B (de) 1990-02-26
DE3390116T1 (de) 1985-01-10
SE8401538D0 (sv) 1984-03-20
ZA835324B (en) 1984-09-26
SE8401538L (sv) 1984-03-20
WO1984000488A1 (en) 1984-02-16

Similar Documents

Publication Publication Date Title
AT381638B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur topischen applikation
ATA377783A (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
DE3485075D1 (de) Pharmazeutische zubereitung zur heilung der erkrankungen der zahnwurzelhaut und verfahren zu deren herstellung.
ATA910981A (de) Verfahren zur herstellung kosmetischer und therapeutischer zusammensetzungen
PT80641A (de) Verfahren zur herstellung von dialkoxypyridinen
ATA117386A (de) Stehtank und verfahren zur herstellung desselben
AT371708B (de) Verfahren zur herstellung von pharmazeutischen einheitsdosierungsformen
ATA164187A (de) Verfahren zur herstellung eines pharmazeutischen pulvers
ATA903983A (de) Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung
AT381025B (de) Verfahren zur herstellung von topischen pharmazeutischen zubereitungen
ATA156187A (de) Verfahren zur herstellung einer festen oralen pharmazeutischen ketotifenzusammensetzung
DE3681946D1 (de) Zahnfaeuleschutzpraeparate und verfahren zur herstellung derselben.
DE3650643D1 (de) Verfahren zur Herstellung von 3-Polyfluoroalkylisoxazolylaminen
AT374682B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
AT365452B (de) Verfahren zur herstellung pharmazeutischer praeparate
AT376436B (de) Verfahren zur herstellung neuer thiophen-2carbons[urederivate und pharmazeutisch vertraeglicher saeure- oder basenadditionssalze davon
AT388293B (de) Stabiles, zahnbelag verhinderndes zahnpflegemittel und verfahren zur herstellung desselben
AT383272B (de) Verfahren zur herstellung von pharmazeutischen tabletten
DE68907097T2 (de) Verfahren zur Herstellung von Ketodiestern.
ATA206087A (de) Verfahren zur herstellung einer octreotid enthaltenden pharmazeutischen zusammensetzung
AT383735B (de) Verfahren zur herstellung von wasserloeslichen pharmazeutischen zusammensetzungen
PT82393A (de) Verfahren zur herstellung von neuen benzoesaeurederivaten
AT378915B (de) Verfahren zur herstellung von antihypertensiven pharmazeutischen zubereitungen
ATA257786A (de) Verfahren zur herstellung galenischer zubereitungen
AT383736B (de) Verfahren zur herstellung von wasserloeslichen pharmazeutischen zusammensetzungen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee